about
The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a reviewSynthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 InhibitorsSynthesis, Structural Analysis, and Biological Evaluation of Thioxoquinazoline Derivatives as Phosphodiesterase 7 InhibitorsSelective Phosphodiesterase 4B Inhibitors: A ReviewVinpocetine as a potent antiinflammatory agentManagement of acute asthma in adults in the emergency department: nonventilatory managementPhosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected miceDrug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis.Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains.Nicotine enhances murine airway contractile responses to kinin receptor agonists via activation of JNK- and PDE4-related intracellular pathways.Psychological factors in asthmaApremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.Advances in targeting cyclic nucleotide phosphodiesterasesNeutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Synergistic effect of caffeine and glucocorticoids on expression of surfactant protein B (SP-B) mRNA.Biochanin a, a phytoestrogenic isoflavone with selective inhibition of phosphodiesterase 4, suppresses ovalbumin-induced airway hyperresponsiveness.Light-dark oscillations in the lung transcriptome: implications for lung homeostasis, repair, metabolism, disease, and drug action.Hesperetin-7,3'-O-dimethylether selectively inhibits phosphodiesterase 4 and effectively suppresses ovalbumin-induced airway hyperresponsiveness with a high therapeutic ratio.Hesperetin, a Selective Phosphodiesterase 4 Inhibitor, Effectively Suppresses Ovalbumin-Induced Airway Hyperresponsiveness without Influencing Xylazine/Ketamine-Induced AnesthesiaPhosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells.Roflumilast inhibits the release of chemokines and TNF-α from human lung macrophages stimulated with lipopolysaccharide.Phosphodiesterase 4B mediates extracellular signal-regulated kinase-dependent up-regulation of mucin MUC5AC protein by Streptococcus pneumoniae by inhibiting cAMP-protein kinase A-dependent MKP-1 phosphatase pathway.Therapeutic options for severe asthmaHeterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of respiratory disease.Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease.Novel medications for asthma: a look at the future.The cytokine network in asthma and chronic obstructive pulmonary diseaseTreating COPD with PDE 4 inhibitors.Using guinea pigs in studies relevant to asthma and COPD.Exacerbation rate, health status and mortality in COPD--a review of potential interventionsIs there a role for antiinflammatory treatment in COPD?Targeting cancer with phosphodiesterase inhibitors.Two Phase Modulation of [Formula: see text] Entry and Cl-/[Formula: see text] Exchanger in Submandibular Glands Cells by DexmedetomidinePhosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension.Genetic basis for personalized medicine in asthma.Emerging drugs for asthma.Pharmacotherapy of critical asthma syndrome: current and emerging therapies.PDE inhibitors currently in early clinical trials for the treatment of asthma.
P2860
Q26785428-62D41104-7A77-4BDB-A2EA-4214B7599006Q27322207-938DF07E-38C7-4149-80FC-5F342659A17EQ27654567-01648310-1F46-41E8-B8B4-6A2A8BA13449Q28081071-D6A59512-3777-4DFF-A58F-95C5193941C6Q28283160-BE8DA4D2-CD8B-4B9B-847C-5A883E0216B2Q28393362-F232E83C-9798-45E3-8395-D166FE70400CQ28477281-06A0C3D5-3A80-446C-B013-6B738A0E3E6AQ30249747-D0762EF2-4FFA-442C-A0BC-9D10373AD171Q33721181-B831BD55-C40A-4F6A-A748-CE1A5DB9FC5FQ33753476-CBF6032C-CF8E-4448-9532-62A426088DDCQ33848593-41AACF61-CA51-401E-A643-9CDC07CCE165Q34091087-28C3E467-0A37-4C79-AF1C-A65AD0F4FC9CQ34139490-A39FE047-D1DE-4CA1-B49D-3149D3003E09Q34149948-5AF541E9-EADA-46C7-B44E-63E4D356C4E9Q34525344-BB02401C-DE2E-4DD0-971D-374AB87AE584Q34706585-80A9EAD5-2046-4832-81C6-5F7DF832C9FEQ35057088-15352A43-723E-4ACB-8EB0-5F90640E4C23Q35576638-32938EAA-C381-4FE4-B62C-F7F533B4EE4DQ35792013-FACF6A0A-25F3-41ED-ADEB-C8E627B48122Q35950168-DE0303F0-4258-4EA0-82C5-574B497C8B31Q35964610-AEEC8C1C-7172-48A7-8FEB-3EB70E5D0E90Q36025380-CF9D4B2F-CDBC-4D22-B852-041B5C1A868FQ36080545-A2EB4630-EFB6-4D56-87B6-10E1E6DA0CD3Q36286252-09C9CA0D-9396-49E8-BC70-F7D8A769A520Q36297777-922632A5-6371-4626-8B50-AC7DAED43632Q36568745-B8496ADB-36B3-4D47-A69E-C83631C72A67Q36687379-C5675A1A-6EB3-405D-A457-C03DD27DEBC5Q36821380-C455D0CC-4735-4B9F-9FC9-4A016B259D70Q36955575-59211952-30A3-4C43-B9EA-AA861370E4CBQ37082594-79658BF0-FA43-4C47-A996-4B1561C07903Q37157003-50521F5B-0EF1-4A87-A0AF-CD5EF5FA3676Q37236165-40608DA7-D3BA-45B2-A462-8492DC5D0D94Q37622935-13599FE1-401F-42C4-896B-73FAEF5F221EQ37650389-1791EEB7-9AA0-42FC-ABDA-07066AE7CE1BQ37672436-D09FC031-F7A4-400E-B049-80B354B91E24Q37893072-5FE47C15-630C-443C-BB46-A6C2D62D6ABAQ37997823-445A14E6-9DCE-46A5-91F7-93D85CDE40B7Q38011270-B3D2780F-6D90-49E4-A458-D70FF16C0CD3Q38157770-2357C07C-FEC4-4B39-BA9D-82B06D47A73DQ38215280-ED440E76-FC86-42B3-8D1C-1D16DAC2B379
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Phosphodiesterase inhibitors in airways disease.
@ast
Phosphodiesterase inhibitors in airways disease.
@en
type
label
Phosphodiesterase inhibitors in airways disease.
@ast
Phosphodiesterase inhibitors in airways disease.
@en
prefLabel
Phosphodiesterase inhibitors in airways disease.
@ast
Phosphodiesterase inhibitors in airways disease.
@en
P1476
Phosphodiesterase inhibitors in airways disease.
@en
P2093
Kian Fan Chung
P304
P356
10.1016/J.EJPHAR.2005.12.059
P407
P577
2006-02-02T00:00:00Z